Cytokinetics Inc (NASDAQ:CYTK) currently has a daily average trading volume of 1.22M but it saw 995187 shares traded in last market. With a market cap of 6.24B USD, the company’s current market price of $53.04 came falling about -3.46 while comparing to the previous closing price of $54.94. In past 52 weeks, the stock remained buoying in the range of price level as high as $110.25 and as low as $30.37. In the recent trading on the day, stock has struck highest price mark of $53.01 while lowest mark touched by it was $54.95.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Goldman which downgraded the stock as “Neutral” in its note to investors issued on August 13, 2024, recommending a price target of between $85 and $60 for it. UBS downgraded its recommendation for the stock as a “Neutral” from “Buy” on January 24, 2024 while assigning a price target range of $61-$92. Morgan Stanley also issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $60 and $90.
Over the week, CYTK’s stock price is moving -4.05% down while it is 0.72% when we observe its performance for the past one month. Year-to-date it is -36.47% down and over the past year, the stock is showing an upside performance of 66.37%.
Currently, Cytokinetics Inc’s total number of outstanding shares is 117.66M. Company’s return on investment (ROI) stands at -62.77%. Stock’s beta reads 0.77. Stock has a price to book (P/B) ratio of 57.43 while price to sale or P/S ratio amounts to 1993.83. Its return on asset (ROA) is -47.34% on average.
